Indoco Remedies Limited (NSE:INDOCO)
223.70
-1.90 (-0.84%)
Oct 23, 2026, 2:34 PM IST
Indoco Remedies Revenue
Indoco Remedies had revenue of 4.68B INR in the quarter ending June 30, 2026, with 6.76% growth. This brings the company's total for the last twelve months to 18.73B, up 12.08% year-over-year. In the fiscal year ending March 31, 2026, Indoco Remedies had annual revenue of 18.45B with 10.84% growth. That makes Indoco Remedies the 17,562nd largest company in the world by revenue and 936th in India.
Revenue (ttm)
18.73B
Revenue Growth
+12.08%
P/S Ratio
1.11
Revenue / Employee
3.12M
Employees
6,000
Market Cap
20.65B
Revenue by Geography
- India 11.24B 62.7%
- Outside India 6.69B 37.3%
Fiscal year ended Mar 31, 2026 See the full Indoco Remedies breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 18.45B | 1.80B | 10.84% |
| Mar 31, 2025 | 16.65B | -1.52B | -8.38% |
| Mar 31, 2024 | 18.17B | 1.49B | 8.91% |
| Mar 31, 2023 | 16.69B | 1.28B | 8.30% |
| Mar 31, 2022 | 15.41B | 2.99B | 24.10% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Solara Active Pharma Sciences | 15.35B |
| Windlas Biotech | 9.42B |
| Orchid Pharma | 8.52B |
| RPG Life Sciences | 7.34B |
| Ind-Swift Laboratories | 6.74B |
| Sigachi Industries | 4.71B |
| Beta Drugs | 4.10B |
| Jagsonpal Pharmaceuticals | 2.94B |
Indoco Remedies News
- 7 days ago - Indoco Remedies Share Price Quietly Does Something Most Mid-Cap Pharma Stocks Won’t - ABC Money
- 2 months ago - Indoco Remedies Transcript: Q1 26/27 - Transcripts
- 2 months ago - Indoco Remedies Quarterly report: Q1 2027 - Filings
- 3 months ago - Pharma sector stocks up today, June 29: Dr. Reddy's Lab jumps 4.11%, Indoco Remedies rises 2.63%, Strides Pharma up 2.70% - Business Upturn
- 3 months ago - Indoco Remedies Goa plant receives EU GMP certification from Malta Medicines Authority - Business Upturn
- 4 months ago - Pharma sector stocks trade mixed on June 22: Cipla up 2.23%, Indoco Remedies gains 2.38%, Wockhardt falls 1.41% - Business Upturn
- 4 months ago - Pharma sector stocks today on June 22: Cipla up 2.23%, Indoco Remedies gains 2.38%, Wockhardt falls 1.41% - Business Upturn
- 4 months ago - Pharma sector stocks today, June 16: Sudeep Pharma up 3.09%, Panacea Biotech gains 0.89%, Indoco Remedies falls 1.13% - Business Upturn